Cargando…

Neurological Sequelae in Adults After E coli O104: H4 Infection-Induced Hemolytic-Uremic Syndrome

In an outbreak of shiga toxin-producing Escherichia coli infections and associated hemolytic-uremic syndrome (STEC O104:H4) in Germany in the year 2011 neurological complications in adult patients occurred unexpectedly frequent, ranging between 48% and 100% in different patient groups. Few is known...

Descripción completa

Detalles Bibliográficos
Autores principales: Schuppner, Ramona, Maehlmann, Justus, Dirks, Meike, Worthmann, Hans, Tryc, Anita B., Sandorski, Kajetan, Bahlmann, Elisabeth, Kielstein, Jan T., Giesemann, Anja M., Lanfermann, Heinrich, Weissenborn, Karin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4753860/
https://www.ncbi.nlm.nih.gov/pubmed/26871766
http://dx.doi.org/10.1097/MD.0000000000002337
_version_ 1782415926221602816
author Schuppner, Ramona
Maehlmann, Justus
Dirks, Meike
Worthmann, Hans
Tryc, Anita B.
Sandorski, Kajetan
Bahlmann, Elisabeth
Kielstein, Jan T.
Giesemann, Anja M.
Lanfermann, Heinrich
Weissenborn, Karin
author_facet Schuppner, Ramona
Maehlmann, Justus
Dirks, Meike
Worthmann, Hans
Tryc, Anita B.
Sandorski, Kajetan
Bahlmann, Elisabeth
Kielstein, Jan T.
Giesemann, Anja M.
Lanfermann, Heinrich
Weissenborn, Karin
author_sort Schuppner, Ramona
collection PubMed
description In an outbreak of shiga toxin-producing Escherichia coli infections and associated hemolytic-uremic syndrome (STEC O104:H4) in Germany in the year 2011 neurological complications in adult patients occurred unexpectedly frequent, ranging between 48% and 100% in different patient groups. Few is known about the long-term effects of such complications and so we performed follow-up exams on 44 of the patients treated for STEC-HUS at Hannover Medical Scool in this observational study. Standardized follow-up exams including neurological and neuropsychological assessments, laboratory testing, magnetic resonance imaging (MRI), and EEG were carried out. Subgroups were examined 2 (n = 34), 7 (n = 22), and 19 (n = 23) months after disease onset. Additionally, at the 19-month follow-up, quality of life, sleep quality, and possible fatigue were assessed. Nineteen months after disease onset 31 patients were reassessed, 22 of whom still suffered from symptoms such as fatigue, headache, and attention deficits. In the neuropsychological assessments only 39% of the patients performed normal, whereas 61% scored borderline pathological or lower. Upon reviewal, the follow-up data most prominently showed a secondary decline of cognitive function in about one-quarter of the patients. Outcome was not related to treatment or laboratory data in the acute phase of the disease nor length of hospitalization. Prognosis of STEC-HUS associated brain dysfunction in adults with regard to severity of symptoms is mostly good; some patients however still have not made a full recovery. Patients’ caretakers have to be aware of possible secondary decline of brain function as was observed in this study.
format Online
Article
Text
id pubmed-4753860
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-47538602016-02-26 Neurological Sequelae in Adults After E coli O104: H4 Infection-Induced Hemolytic-Uremic Syndrome Schuppner, Ramona Maehlmann, Justus Dirks, Meike Worthmann, Hans Tryc, Anita B. Sandorski, Kajetan Bahlmann, Elisabeth Kielstein, Jan T. Giesemann, Anja M. Lanfermann, Heinrich Weissenborn, Karin Medicine (Baltimore) 5300 In an outbreak of shiga toxin-producing Escherichia coli infections and associated hemolytic-uremic syndrome (STEC O104:H4) in Germany in the year 2011 neurological complications in adult patients occurred unexpectedly frequent, ranging between 48% and 100% in different patient groups. Few is known about the long-term effects of such complications and so we performed follow-up exams on 44 of the patients treated for STEC-HUS at Hannover Medical Scool in this observational study. Standardized follow-up exams including neurological and neuropsychological assessments, laboratory testing, magnetic resonance imaging (MRI), and EEG were carried out. Subgroups were examined 2 (n = 34), 7 (n = 22), and 19 (n = 23) months after disease onset. Additionally, at the 19-month follow-up, quality of life, sleep quality, and possible fatigue were assessed. Nineteen months after disease onset 31 patients were reassessed, 22 of whom still suffered from symptoms such as fatigue, headache, and attention deficits. In the neuropsychological assessments only 39% of the patients performed normal, whereas 61% scored borderline pathological or lower. Upon reviewal, the follow-up data most prominently showed a secondary decline of cognitive function in about one-quarter of the patients. Outcome was not related to treatment or laboratory data in the acute phase of the disease nor length of hospitalization. Prognosis of STEC-HUS associated brain dysfunction in adults with regard to severity of symptoms is mostly good; some patients however still have not made a full recovery. Patients’ caretakers have to be aware of possible secondary decline of brain function as was observed in this study. Wolters Kluwer Health 2016-02-12 /pmc/articles/PMC4753860/ /pubmed/26871766 http://dx.doi.org/10.1097/MD.0000000000002337 Text en Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 5300
Schuppner, Ramona
Maehlmann, Justus
Dirks, Meike
Worthmann, Hans
Tryc, Anita B.
Sandorski, Kajetan
Bahlmann, Elisabeth
Kielstein, Jan T.
Giesemann, Anja M.
Lanfermann, Heinrich
Weissenborn, Karin
Neurological Sequelae in Adults After E coli O104: H4 Infection-Induced Hemolytic-Uremic Syndrome
title Neurological Sequelae in Adults After E coli O104: H4 Infection-Induced Hemolytic-Uremic Syndrome
title_full Neurological Sequelae in Adults After E coli O104: H4 Infection-Induced Hemolytic-Uremic Syndrome
title_fullStr Neurological Sequelae in Adults After E coli O104: H4 Infection-Induced Hemolytic-Uremic Syndrome
title_full_unstemmed Neurological Sequelae in Adults After E coli O104: H4 Infection-Induced Hemolytic-Uremic Syndrome
title_short Neurological Sequelae in Adults After E coli O104: H4 Infection-Induced Hemolytic-Uremic Syndrome
title_sort neurological sequelae in adults after e coli o104: h4 infection-induced hemolytic-uremic syndrome
topic 5300
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4753860/
https://www.ncbi.nlm.nih.gov/pubmed/26871766
http://dx.doi.org/10.1097/MD.0000000000002337
work_keys_str_mv AT schuppnerramona neurologicalsequelaeinadultsafterecolio104h4infectioninducedhemolyticuremicsyndrome
AT maehlmannjustus neurologicalsequelaeinadultsafterecolio104h4infectioninducedhemolyticuremicsyndrome
AT dirksmeike neurologicalsequelaeinadultsafterecolio104h4infectioninducedhemolyticuremicsyndrome
AT worthmannhans neurologicalsequelaeinadultsafterecolio104h4infectioninducedhemolyticuremicsyndrome
AT trycanitab neurologicalsequelaeinadultsafterecolio104h4infectioninducedhemolyticuremicsyndrome
AT sandorskikajetan neurologicalsequelaeinadultsafterecolio104h4infectioninducedhemolyticuremicsyndrome
AT bahlmannelisabeth neurologicalsequelaeinadultsafterecolio104h4infectioninducedhemolyticuremicsyndrome
AT kielsteinjant neurologicalsequelaeinadultsafterecolio104h4infectioninducedhemolyticuremicsyndrome
AT giesemannanjam neurologicalsequelaeinadultsafterecolio104h4infectioninducedhemolyticuremicsyndrome
AT lanfermannheinrich neurologicalsequelaeinadultsafterecolio104h4infectioninducedhemolyticuremicsyndrome
AT weissenbornkarin neurologicalsequelaeinadultsafterecolio104h4infectioninducedhemolyticuremicsyndrome